People in the News - News Updates
Find out the latest news about DCEG Staff: awards and recognition, hirings and promotions, and engagement at scientific conferences.
-
2022 AACR Annual Meeting Features DCEG Research
DCEG investigators and fellows presented their research at the 2022 American Association for Cancer Research (AACR) Annual Meeting.
-
Shahinaz Gadalla Awarded Scientific Tenure by the NIH
In April 2022, Shahinaz Gadalla, Ph.D., M.B.Bch., was awarded scientific tenure by the NIH and promoted to senior investigator in the Clinical Genetics Branch. Dr. Gadalla is a highly collaborative, internationally recognized physician scientist with expertise in cancer epidemiology and clinical medicine. She investigates the role of genetic factors in cancer etiology and explores elements that may modify disease risk among high-risk individuals.
-
Sam Mbulaiteye Named 2022 Scientist of the Year by the Lymphoma Foundation of America
Dr. Mbulaiteye, senior investigator in the Infections and Immunoepidemiology Branch, was recently recognized by the Lymphoma Foundation of America with their 2022 Scientist of the Year Award. As a part of this award, he directed a donation from the foundation to a study site in Uganda for medical care for children with Burkitt lymphoma.
-
2022 CCR-DCEG Flex Awards Announced
Three projects were funding through the Flex Award Program, including two investigations of health disparities. Investigators from DCEG: Drs. Jiyeon Choi, Maria Teresa Landi, Tongwu Zhang, Gretchen Gierach, Aimée R. Kreimer, Lisa Mirabello, and Mark Schiffman.
-
Laura Beane Freeman Re-elected to Second Term as Women Scientist Advisor
Dr. Beane Freeman has been re-elected by her peers to a second term as DCEG Women Scientist Advisor (WSA).
-
President’s Cancer Panel Addresses Gaps in Cancer Screening for All Americans
In February 2022, the Panel released their report “Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access,” in which they identify more effective and equitable implementation of cancer screening as a significant opportunity for the National Cancer Program, to accelerate the decline in cancer deaths and, in some cases, prevent cancer through detection and removal of precancerous lesions.
-
2021 NCI Director’s Award Ceremony, DCEG Staff Recognized
Several DCEG staff were honored at the 2021 NCI Director’s Awards ceremony for their efforts in advancing understanding of the etiology of multiple myeloma, non-smoking-related lung cancer; mosaic chromosomal alterations and risk of acquiring infectious disease; their work on The United States – Latin America Cancer Research Network Team; leadership on the Equity and Inclusion Program; and for years of continued service to the NCI.
-
2022 NCI Director's Intramural Innovation Awards
Ian Buller, Ph.D., Erping Long, M.D., Ph.D., Zeni Wu, Ph.D., M.P.H., Tongwu Zhang, Ph.D., and Wei Zhao, Ph.D., received the 2022 NCI Director’s Innovation Awards, designed to support development of highly innovative approaches and technology aimed at significant cancer–related problems.
-
Jonathan Hofmann Awarded Scientific Tenure by the NIH
Jonathan Hofmann, Ph.D., M.P.H., was awarded scientific tenure by the NIH and promoted to senior investigator in the Occupational and Environmental Epidemiology Branch. He is an internationally recognized leader in using molecular approaches to study the etiology of kidney cancer, multiple myeloma, and other malignancies.
-
2022 NCI Career Development Program Selections
Postdoctoral fellows Burak Altintas, M.D., in the Clinical Genetics Branch, Brittany Lord, Ph.D., M.P.H., M.S., and Waruiru Mburu, Ph.D., M.P.H., in the Integrative Tumor Epidemiology Branch, Omonefe Omofuma, Ph.D., M.S., in the Metabolic Epidemiology Branch, and Elisa Pasqual, Ph.D., in the Radiation Epidemiology Branch were selected for the 2022 NCI Career Development Program (CDP).
-
Roni Falk Retires from DCEG
Roni Falk, M.S., staff scientist in the Metabolic Epidemiology Branch (MEB) retired after 38 years of service to the NCI. Ms. Falk made critical contributions to epidemiologic studies on endogenous hormones and cancer risk.
-
Li Cheung Appointed Earl Stadtman Tenure-track Investigator
Dr. Cheung was appointed Earl Stadtman tenure-track investigator in the Biostatistics Branch. Dr. Cheung studies the etiology and natural history of cancer, particularly focusing on the development, implementation, and translation of statistical methodology to understand cancer progression and to construct actionable guidelines for the prevention and early detection of disease.
-
Zhiwei Liu Appointed to Tenure Track in the Infections and Immunoepidemiology Branch
Dr. Liu investigates the role of infection and immune response in the etiology of virus-related cancers. Utilizing high-throughput omics technologies and other cutting-edge techniques, as well as classical epidemiologic methods, Dr. Liu seeks to identify opportunities for prevention and screening and to clarify the role of host genetics in disease progression.
-
2021 Awards Announced at DCEG Town Hall
In November 2021, Dr. Stephen Chanock announced numerous awards received by DCEG staff for their research excellence, mentoring, and service, including the NIH Director’s Awards, NCI Outstanding Mentor Awards, and 2022 DCEG Fellows Awards for Research Excellence (DFARE).
-
Report from the 2021 Workshop on Breast Cancer and the Environment
In May 2021, several experts from DCEG participated in the workshop “Breast Cancer and the Environment: Controversial and Emerging Exposures,” cohosted by the NCI and the National Institute of Environmental Health Sciences (NIEHS). The workshop was co-chaired by Monserrat García-Closas and Dr. Dale Sandler of NIEHS.
-
New Guidelines for Cervical Screening and Management Based on DCEG Research
New guidelines for screening and clinical management of cervical precancer from the American Cancer Society, a U.S. consensus committee, and the World Health Organization, are based on research by DCEG investigators. These guidelines utilize a risk-based approach and focus on HPV testing for primary screening. Paired with vaccination against HPV, they support the global effort to accelerate cervical cancer control.
-
Laura Beane Freeman Elected Chair of the Management Committee of EPICOH
Laura Beane Freeman, Ph.D., senior investigator in the Occupational and Environmental Epidemiology Branch (OEEB), was elected chair of the Management Committee of Epidemiology in Occupational Health Conference (EPICOH), the largest occupational epidemiologic society.
-
Director’s Update: Welcoming New Leaders to the NCI
Dr. Stephen Chanock welcomes the newest director-level scientist to NCI, Dr. Katrina Goddard, and reflects on DCEG’s participation in numerous collaborations across the NCI divisions which have yielded research innovations and foundational resources.
-
NCI Study Highlights Pandemic’s Disproportionate Impact on Black, American Indian/Alaska Native, and Latino Individuals
The global COVID-19 pandemic has taken a toll on Black, American Indian/Alaska Native, and Latino individuals in the United States, causing more deaths by population size, both directly and indirectly, in these groups compared with White or Asian individuals. The findings, from a large surveillance study led by Meredith Shiels, Ph.D., appeared October 5, 2021, in Annals of Internal Medicine.
-
DCEG Researchers Featured in Fifty Years of the National Cancer Act Commemoration
Aimée Kreimer, Ph.D., Joseph Fraumeni, Jr., M.D., Francine S. Baker, M.S., and Ludmila Prokunina-Olsson, Ph.D., and Frank J. Colón-Matos, B.S., share their research and personal experiences as part of the commemoration of the 50th anniversary of the National Cancer Act.